SCHEMBL6807225

SCHEMBL6807225

Cc1ccc(-c2cc(C)ccn2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.70
CCR5 P51681 1/20 0.70
CCR8 P51685 1/20 0.70
CYP2A6 P11509 1/20 0.58
UHRF1 Q96T88 1/20 0.50
METAP2 P50579 1/20 0.48
MEN1 O00255 6/20 0.47
KMT2A Q03164 6/20 0.47
KDM4E B2RXH2 3/20 0.46
NOS3 P29474 1/20 0.46
NOS1 P29475 1/20 0.46
NOS2 P35228 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
TP53 P04637 2/20 0.46
ABL1 P00519 4/20 0.46
BCR P11274 4/20 0.46
KDM1A O60341 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
TGFBR1 P36897 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29463685 1.00 CCR1 (0.70) CCR1CCR5CCR8CYP2A6UHRF1
SCHEMBL31695263 0.95 CCR1 (0.76) CCR1CCR5CCR8CYP2A6UHRF1
SCHEMBL27344644 0.95 CCR1 (0.76) CCR1CCR5CCR8CYP2A6UHRF1
SCHEMBL17406767 0.85 CCR1 (0.61) CCR1CCR5CCR8CYP2A6UHRF1
SCHEMBL842265 0.85 CCR1 (0.61) CCR1CCR5CCR8CYP2A6UHRF1
SCHEMBL5956691 0.85 CCR1 (0.61) CCR1CCR5CCR8CYP2A6UHRF1
SCHEMBL2190158 0.85 CYP2A6 (0.62) CCR1CCR5CCR8CYP2A6UHRF1
SCHEMBL6183900 0.85 CCR1 (0.61) CCR1CCR5CCR8CYP2A6UHRF1
SCHEMBL17051592 0.85 CYP2A6 (0.57) CCR1CCR5CCR8CYP2A6UHRF1
SCHEMBL842170 0.84 CYP2A6 (0.67) CCR1CCR5CCR8CYP2A6UHRF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034027-A1 METHOD FOR PREPARING GLASS NANOSTRUCTURES AND NANOSTRUCTURED SUBSTRATES THEREOF CORNING INCORPORATED 2025-01-30 US disclosed
US-12022832-B2 Compounds and methods for treating nematode infections THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2024-07-02 US disclosed
US-20240074301-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-02-29 US disclosed
US-11864458-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2024-01-02 US disclosed
US-20230345811-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-26 US disclosed
US-20230345812-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-26 US disclosed
US-20230331757-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-19 US disclosed
US-20230320188-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-05 US disclosed
US-20230309396-A1 Host Materials for Electroluminscent Devices UNIVERSAL DISPLAY CORPORATION 2023-09-28 US disclosed
US-20230287011-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-09-14 US disclosed
CN-112552353-A Iridium metal complex and organic photoelectric element using same 浙江华显光电科技有限公司 2021-03-26 CN disclosed
US-10224491-B2 Amine-based compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2019-03-05 US disclosed
US-10208026-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2019-02-19 US disclosed
US-9957441-B2 Amine-based compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-01 US disclosed
WO-2017076187-A1 1,4(1,4)-DIPHENYLHEXACYCLOPHANE-12,43-DIYL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 江苏豪森药业集团有限公司 2017-05-11 WO disclosed
US-20150266863-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2015-09-24 US disclosed
US-20150266863-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2015-09-24 US disclosed
US-20040087623-A1 Pyrazole derivatives against tgf overexpression GLAXO GROUP LIMITED (GB) 2004-05-06 US disclosed
EP-1355903-A1 PYRAZOLE DERIVATIVES AGAINST TGF OVEREXPRESSION GLAXO GROUP LIMITED (GB) 2003-10-29 EP disclosed
WO-2002066462-A1 PYRAZOLE DERIVATIVES AGAINST TGF OVEREXPRESSION GLAXO GROUP LIMITED (GB) 2002-08-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12022832-B2 Compounds and methods for treating nematode infections HNMT, NISCH, HRH2 CCR1 1016/4885CCR5 1571/4885CCR8 1321/4885
US-20230309396-A1 Host Materials for Electroluminscent Devices CRHR1, CRHR2, CRH CCR1 27/4885CCR5 158/4885CCR8 6/4885
US-20230345812-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OPRD1, OCIAD2 CCR1 563/4885CCR5 1162/4885CCR8 2173/4885
US-10224491-B2 Amine-based compound and organic light-emitting device including the same AOC2, TYR, TAAR1 CCR1 2658/4885CCR5 3158/4885CCR8 4038/4885
US-20230320188-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, MLX CCR1 802/4885CCR5 1443/4885CCR8 1729/4885
US-20230287011-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OXGR1, OCIAD1 CCR1 3163/4885CCR5 1891/4885CCR8 2473/4885
US-11864458-B2 Organic electroluminescent materials and devices RAP1A, L1CAM, SOD1 CCR1 1295/4885CCR5 3216/4885CCR8 2677/4885
US-20240074301-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ICOSLG, OCIAD2, OSBP CCR1 2004/4885CCR5 786/4885CCR8 869/4885
US-10208026-B2 Organic electroluminescent materials and devices ZYX, LBR, LOXL1 CCR1 1816/4885CCR5 2572/4885CCR8 549/4885
US-20040087623-A1 Pyrazole derivatives against tgf overexpression TGFBR1, SMAD3, TGFBR2 CCR1 824/4885CCR5 1748/4885CCR8 2395/4885
US-20230331757-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, SSB, L1CAM CCR1 744/4885CCR5 1474/4885CCR8 1782/4885
US-20150266863-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ZYX, LBR, LOXL1 CCR1 1816/4885CCR5 2572/4885CCR8 549/4885
US-20230345811-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OPRD1, L1CAM, OPRM1 CCR1 1427/4885CCR5 1275/4885CCR8 2672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.